Meihao Medical Group Co. Ltd. (1947) Fair Value & Analysis
Healthcare · HK · Market cap HK$306M
Fair value as of: Aug 13, 2026
From 9 valuation models · updated 3 days ago
Share price +18.7% over the past month.
A solid business, but screening 44% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (HK$0.3500). The favourable scenario is already priced in.
- Solid but not exceptional quality (57/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
44‑month range HK$0.2800 – HK$0.7020 · fair‑value band HK$0.2600 – HK$0.3500 · the HK$0.5400 price screens above the HK$0.3000 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Meihao Medical Group Co. Ltd. (1947) currently trades at HK$0.5400, while our model-based Fair Value estimate is HK$0.3000, implying the stock looks roughly 44.4% overvalued today. The Quality Score stands at 57/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Meihao Medical Group Co. Ltd. generated revenue of HK$102M at a net margin of -14.1%. Revenue grew 42.2% year over year. It earns a return on equity of -12.4%. Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$0.2600 (bear case) to HK$0.3500 (bull case); at HK$0.5400, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 11% below its 52-week high and 93% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at -44%, 1947 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 9 models by family
Widest divergence: DCF Models (HK$0.2900) versus Dividend Discount (HK$0.1200). Highest evidence: Growth DCF (80).
Notify me when 1947 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 58 · Market factors (momentum, volatility) 71
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Meihao Medical Group Co., Ltd, an investment holding company, provides dental services to individuals in Mainland China.
Full company description
Meihao Medical Group Co., Ltd, an investment holding company, provides dental services to individuals in Mainland China. The company offers general dentistry that offers examination, diagnosis, prevention, and treatment of disorders of the orofacial region; orthodontics and cosmetic dentistry that includes correction of misalignment and incorrect relation between the teeth as well as skeletal abnormalities; reparative dentistry for restoring the function, integrity, and morphology of missing tooth structure; and implant dentistry that focuses on surgically placing fixture dental implants in the patients jawbone to replace the damaged or missing tooth with prosthetics. It also owns and operates private dental hospitals and clinic. The company was founded in 2011 and is headquartered in Wenzhou, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Meihao Medical Group Co. Ltd. reported revenue of HK$102M in FY2025 versus HK$105M in FY2021, a compound −0.9%/yr. Reported net income was −HK$14.3M in FY2025.
1947 screens 44% overvalued. Compare with HCA Healthcare, Inc →
Peer Group
Medical Care Facilities · 266 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $414.59 | $547.67 | +32% |
| Fresenius SE FRE | €46.82 | €32.15 | -31% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | -46% |
| Tenet Healthcare Corporation THC | $266.79 | $330.25 | +24% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.97 | R$47.31 | +39% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,565 | ₹2,955 | -65% |
| Aier Eye Hospital Group 300015 | ¥8.87 | ¥7.67 | -14% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,008 | ₹284.87 | -72% |
| Bangkok Dusit Medical Services Public Company BDMS | 19.70 THB | 18.57 THB | -6% |
Compare Meihao Medical Group Co. Ltd. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Meihao Medical Group Co. Ltd. (1947) overvalued or undervalued?
What is the fair value of 1947?
What is the quality score of 1947?
What is the revenue of Meihao Medical Group Co. Ltd. (1947)?
What is the net profit margin of 1947?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Meihao Medical Group Co. Ltd. and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.